Apogee Therapeutics, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Goods Sold | 408K | -400K | 400K | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | -408K | 400K | -400K | 0 | 0 | 0 | 0 | 0 |
| R&D Expenses | 60.8M | 58.4M | 54.2M | 55.7M | 46.4M | 60.2M | 45.7M | 33.2M |
| Operating Expenses | 82.4M | 78.5M | 70.9M | 73.2M | 63.1M | 75.9M | 58.7M | 44.1M |
| Operating Income | -82.8M | -78.1M | -71.3M | -73.2M | -63.1M | -75.9M | -58.7M | -44.1M |
| Other Income / Gains | 8.7M | 8.7M | 6.3M | 7.1M | 7.8M | 8.7M | 9.7M | 10.3M |
| Net Income | -74.1M | -69.4M | -65.0M | -66.1M | -55.3M | -67.2M | -49.0M | -33.8M |
| EPS (Diluted) | -1.06 | -1.03 | -1.11 | -1.13 | -0.95 | -1.22 | -0.86 | -0.60 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General And Administrative Expenses | 22.0M | 20.1M | 17.1M | 17.1M | 16.6M | 15.7M | 13.0M | 10.9M |
| Selling And Marketing Expenses | -408K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 21.5M | 20.1M | 17.1M | 17.1M | 16.6M | 15.7M | 13.0M | 10.9M |
| Other Expenses | 0 | -68K | -400K | 325K | 143K | 0 | 0 | 0 |
| Cost And Expenses | 82.8M | 78.1M | 71.3M | 73.2M | 63.1M | 75.9M | 58.7M | 44.1M |
| Interest Income | 8.7M | -21.3M | 6.3M | 7.1M | 7.8M | 8.7M | 9.7M | 10.3M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation And Amortization | 408K | 406K | 400K | 399K | 207K | 76K | 48K | 36K |
| Ebitda | -82.4M | -77.7M | -64.6M | -72.8M | -62.9M | -75.8M | -58.6M | -44.1M |
| Ebitdaratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | -74.0M | -69.3M | -65.0M | -66.0M | -55.3M | -67.2M | -49.0M | -33.8M |
| Income Before Tax Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense | 79K | 62K | 61K | 72K | 83K | 18K | 0 | 0 |
| Net Income Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Epsdiluted | -1.06 | -1.03 | -1.11 | -1.13 | -0.95 | -1.22 | -0.86 | -0.60 |
| Weighted Average Shs Out | 69.7M | 60.7M | 58.8M | 58.4M | 58.2M | 55.2M | 56.8M | 56.5M |
| Weighted Average Shs Out Dil | 69.7M | 60.7M | 58.8M | 58.4M | 58.2M | 55.2M | 56.8M | 56.5M |